Atlas Trials

A Study on the Short - Course Treatment Regimen Containing Pretomanid for Diabetes Mellitus Complicated With Rifampicin - Resistant/Multidrug - Resistant Pulmonary Tuberculosis

Clinical trial NCT07191834 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07191834
Sponsor
Wuhan Pulmonary Hospital
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Rifampicin-resistant/Multidrug-resistant Pulmonary TuberculosisType 2 Diabetes Mellitus (T2DM)Pretomanid
Start date
2025-09-30
Primary completion
2026-09-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.